cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Perkinelmer Inc
8 own
5 watching
Current Price
$141.75
$-2.63
(-1.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
17,891.69M
52-Week High
52-Week High
190.56
52-Week Low
52-Week Low
113.46
Average Volume
Average Volume
0.76M
Dividend Yield
Dividend Yield
0.001658
P/E Ratio
P/E Ratio
16.0539
iconMarket Capitalization17,891.69M
icon52-Week High190.56
icon52-Week Low113.46
iconAverage Volume0.76M
iconDividend Yield0.001658
iconP/E Ratio16.0539
What does the Perkinelmer Inc do?
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates through two segments, Discovery and Analytical Solutions and Diagnostics. The Discovery and Analytical Solutions segment develops and provides analytical technologies, solutions, and services that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. It also provides solutions to farmers and food producers; an analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, food, lubricant, petrochemical, and polymer industries; and laboratory services. This segment's offers a suite of solutions, including reagents, liquid handling systems, and detection and imaging technologies that enable scientists to enhance life sciences research and drug discovery processes. Its research portfolio includes a range of systems consisting of imaging, detection, and extraction instrumentation for use on in vitro, ex vivo, and in vivo models, analysis hardware, and software; and a range of consumable products, including drug discovery and research reagents. The Diagnostics segment provides early detection for genetic disorders from pregnancy to early childhood, as well as flat panel X-ray detectors and infectious disease testing for the diagnostics market. This segment also develops technologies that enable and support sample-to-sequencer workflow using next-generation DNA sequencing for applications in oncology, genetic testing, and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Perkinelmer Inc make?
News & Events about Perkinelmer Inc.
Accesswire
19days ago
Mr. Rongen appointed as CEO and member of the Board bringing 30 years of executive leadership experience and expertise across a number of therapeutic areasBolstered expertise on Board of Directors with addition of Dr. Rogers who brings significant leadership and expertise spanning both public and...
Business Wire
1month ago
PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 8:15 a.m. PT. Prahlad Singh, president and chief executive officer, will...
Zolmax
1month ago
PerkinElmer, Inc. (NYSE:PKI Get Rating) has earned a consensus rating of Hold from the thirteen research firms that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the ...
Business Wire
2 months ago
PerkinElmer Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2022 Stifel Healthcare Conference on Wednesday, November 16, 2022 at 9:10 a.m. ET in New York, NY. Max Krakowiak, senior vice president and chief...
Business Wire
3 months ago
PerkinElmer Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today released its 2022 Environmental, Social and Governance (ESG) Report. The report describes progress on the Companys previously stated goals, builds on the Companys ESG commitments and summarizes its...
Frequently Asked Questions
Frequently Asked Questions
What is Perkinelmer Inc share price today?
plus_minus_icon
Can Indians buy Perkinelmer Inc shares?
plus_minus_icon
How can I buy Perkinelmer Inc shares from India?
plus_minus_icon
Can Fractional shares of Perkinelmer Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Perkinelmer Inc stocks?
plus_minus_icon
What is today’s traded volume of Perkinelmer Inc?
plus_minus_icon
What is today’s market capitalisation of Perkinelmer Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Perkinelmer Inc?
plus_minus_icon
What percentage is Perkinelmer Inc down from its 52-Week High?
plus_minus_icon
What percentage is Perkinelmer Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$141.75
$-2.63
(-1.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00